<DOC>
	<DOCNO>NCT01534247</DOCNO>
	<brief_summary>The purpose study ass whether pharmacokinetic interaction CAZ-AVI metronidazole .</brief_summary>
	<brief_title>A Study Assess Levels CAZ-AVI Metronidazole Blood When Given Together Separately</brief_title>
	<detailed_description>A Phase I , Open-Label , 3-way Crossover , Pharmacokinetic Drug-Drug Interaction Study ceftazidime avibactam ( CAZ-AVI ) Metronidazole Administered Alone Combination Healthy Subjects</detailed_description>
	<mesh_term>Avibactam</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Ceftazidime</mesh_term>
	<criteria>Provision sign date , write informed consent prior studyspecific procedure . Healthy male female subject age 18 50 year ( inclusive ) suitable vein cannulation repeat venipuncture ; female subject must post menopausal surgically sterile . Male subject willing use barrier contraception ie , condom , first day investigational product administration 3 month last administration investigational product . Have body mass index ( BMI ) 19 30 kg/m2 Be able understand willing comply study procedure , restriction , requirement , judge Investigator History clinically significant disease disorder , opinion Investigator , may either put subject risk participation study , influence result subject 's ability participate study History presence gastrointestinal , hepatic renal disease , condition know interfere absorption , distribution , metabolism , excretion drug Known history serious allergy , hypersensitivity ( eg , anaphylaxis ) , serious reaction carbapenem cephalosporin antibiotic betaactam antibiotic investigational product administer part study Any clinically significant illness , medical/surgical procedure trauma within 4 week prior first administration investigational product Any clinically significant abnormality physical examination , ECG , clinical chemistry , haematology , urinalysis result , judge Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Phase I</keyword>
	<keyword>drug drug</keyword>
	<keyword>CAZ-AVI</keyword>
	<keyword>Healthy volunteer</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>open label</keyword>
	<keyword>metronidazole</keyword>
	<keyword>safety</keyword>
</DOC>